Description

The Hepatic Fibrosis Test YRA317 and YRA321 are essential diagnostics tools designed for the early detection and management of liver fibrosis. These tests allow for the timely detection of fibrosis in the liver, a condition that, if caught early, can be treated to prevent the onset of cirrhosis, thereby improving the patient’s quality of life and prognosis. Compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, these tests offer a reliable and efficient way to monitor liver health.

Market Price

The market price for the Hepatic Fibrosis Test kits varies depending on the supplier and order volume. Typically, prices range from $150 to $300 per test kit. For a precise quote, it’s recommended to request a quotation or take advantage of the Kalstein Plus platform for automatic quotations, ensuring you get competitive pricing for your diagnostic needs.

Frequently Asked Questions

What parameters do the YRA317 and YRA321 tests measure? The YRA317 measures PIIINP, while the YRA321 measures CG, providing comprehensive insights into liver fibrosis status.

What is the storage requirement for these test kits? To maintain the integrity and accuracy of the tests, they should be stored at temperatures between 2-8°C.

Are these tests certified? Yes, the tests carry certifications such as CE, ISO13485, and FSC, assuring high quality and reliability.

Advantages and Disadvantages

Advantages of the Hepatic Fibrosis Test include high accuracy in early disease detection, compatibility with existing analyzers, and ease of use in clinical settings. However, potential disadvantages could include the higher cost per test and the need for specialized equipment for analysis.

Field Use

In practical scenarios, the Hepatic Fibrosis Test is used in hospitals and laboratories that focus on liver health and disease prevention. They are particularly useful in routine screenings for at-risk populations and monitoring fibrosis progression in patients with pre-existing liver conditions.

Recommendations

For optimal results, it’s recommended that users follow the provided storage and handling guidelines closely. Regular calibration of the analyzers used in conjunction with these tests will ensure consistent accuracy. Customers are also encouraged to use the Kalstein Plus platform to generate quotations and stay informed about the latest updates in testing technology.

Features

• Early detection capabilities to reverse liver fibrosis progression
• Compatible with CLIA analyzers YR06389 and YR06390
• Certified with CE, ISO13485, and FSC standards
• Convenient packaging options for ease of use
• Storage at controlled temperatures for test integrity

Technical Specifications